PharmEasy is a multinational e-pharmacy company offering medicines, healthcare products and services like diagnostics and telehealth via. online. It facilitates a supper app that is integrated with various kinds of functionalities revolving around healthcare products and services that can be availed right from the comfort of your home. Furthermore, the pharmaceutical industry is expected to hit 57 billion USD by the end of the financial year 2025 i.e. an annual growth rate of 8% with an industry export growth of 7%. Therefore if you are looking forward to investing in any pharmaceuticals and healthcare stock, you can consider investing in PharEasy IPO. Read along to learn more about the PharmEasy IPO.
Also Read: IPO investment strategy: Tips for investing in an IPO
Table of Content
About the Company
PharmEasy provides 1 lakh+ medicines and healthcare products across multiple categories through its retail partners spread all over India. It is a consumer healthcare super app that ensures home delivery of medicines, consumer healthcare products, teleconsultations and comprehensive diagnostic test services. Customers can place their orders via websites and Apps. They’ll get their products delivered within 4 hours. PharmEasy offers guaranteed delivery within 24 hours to 48 hours.
The company firmly believes that a good work culture is an important ingredient to the success of a company. The team members are encouraged to work as a single unit and take ownership. The World Consulting and Research Corporation rated PharmEasy as one of the “most trusted brands in 2016.”
The DRHP (Draft Red Herring Prospectus) was filed by API Holdings, which happens to be PharmEasy’s parent company.
Strengths
Check the qualitative factors of API Holdings below:
- PharmEasy is a highly recognised brand.
- The company has a technology-driven approach.
- API Holdings has a good business model. It maintains good stakeholder relationships across the healthcare value chain.
- Scaled supply chain capabilities are a major benefit of API Holdings.
- The company has a resilient business model which is scalable. It also enjoys good financial metrics.
- It has a good record of acquiring businesses and integrating them.
- The founding and professional management team are quite experienced, committed and passionate.
Risks Involved
Check the risks involved with investing in this IPO:
- The company’s success is heavily dependent on the digital healthcare industry’s growth which, in turn, is reliant on consumers’ acceptance of digital healthcare services.
- If the PharmEasy marketplace is not operated well, it may have a negative impact on the business.
- If the company fails to maintain its brand image and reputation among various participants on its platform, the brand and reputation may suffer damage.
- The operating history of PharmEasy is quite limited in the digital healthcare industry. Its recent acquisitions may make it difficult to check the challenges and risks it may encounter.
- API Holdings is subject to various healthcare regulatory requirements. Any non-compliance may have a materially negative impact on the overall business of the company.
Also Read: Risk of investing in IPO
Why Should You Invest in API Holdings IPO?
API Holdings is, undoubtedly, the largest digital healthcare platform in India. It operates an integrated end-to-end business that addresses people’s healthcare needs through fulfilment capabilities and technology. The customised technology platform of API Holdings provides each stakeholder with the benefit of an interconnected network.
API Holdings Financials:
Check the key financial details of API Holdings:
| Particulars | For the Financial Year/Period Ending (in Rs. million) | ||
| June 30, 2021 | March 31, 2021 | March 31, 2020 | |
| Total Assets | 58,435.61 | 49,053.44 | 5,724.75 |
| Total Liabilities | 12,031.63 | 13,241.69 | 3,262.33 |
| Total Expenses | 15,270.17 | 29,809.28 | 10,844.04 |
| Total Revenue | 12,072.60 | 23,606.62 | 7,374.48 |
| Profit/Loss After Tax | (3,138.91) | (6,413.36) | (3,352.79) |
| EBITDA | (2925.86) | (5,693.27) | (3,862.05) |
How to Apply for PharmEasy IPO?
Follow these steps to subscribe to PharmEasy IPO:
Step 1: Visit the Bajaj Trading Platform. Sign in with your credentials.
Step 2: Go to the Menu and click on ‘Open IPOs’.
Step 3: Click on your preferred IPO on the redirected page.
Step 4: Fill up the required details along with your UPI ID to apply.
Also Read: How To Apply For An IPO?
Summary
PharmEasy is one of the leading e-pharmaceutical companies in India. Their super app enables customers to avail medicines, healthcare products, telehealth services, and diagnostics right from the convenience of their home.
Their tech-driven approach and scalable business model ensure growth in their upcoming ventures and acquire a significant market share in the industry.
You can expect the IPO to go live shortly this year. However, it is always recommended to go through the RHP carefully in order to make an informed decision.
PharmEasy IPO FAQs
The important businesses that fall under API Holdings Limited include Dialhealth, Docon, MedLife, Aknamed, Retailio, Redbook and Ascent.
Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, BofA Securities India Limited, Citigroup Global Markets India Private Limited and J M Financial Limited are the book-running lead managers of API Holdings IPO.
Link Intime India Private Limited is the registrar of this IPO.
PharmEasy is a digital health start-up that offers medicine deliveries, teleconsultation and diagnostic test sample collection. It operates a healthcare platform that combines the offerings of hospitals, pharma companies and consultants.
Details of when PharmEasy IPO allotment will be available have not been revealed as of yet.
We do not know the launch date of PharmEasy IPO. Its details will be updated here when API Holdings Ltd decides to open its IPO.
Read More Blogs
